pravastatin has been researched along with Cardiac Remodeling, Ventricular in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (75.00) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Birukov, A; Dechend, R; Geisberger, S; Golic, M; Haase, N; Herse, F; Heuser, A; Kräker, K; Müller, DN; O'Driscoll, JM; Patey, O; Schütte, T; Thilaganathan, B; Verlohren, S | 1 |
| Bin, J; Cao, S; Liao, Y; Wang, X; Xu, D; Zeng, Z | 1 |
| Baek, SH; Cho, HJ; Jeon, HK; Kang, SM; Kim, HY; Lee, HY; Shin, JH | 1 |
| Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Liao, Y; Minamino, T; Takashima, S; Zhao, H | 1 |
| Abouelnaga, ZA; Alhaj, MA; Awad, MM; Citro, LA; El-Sayed, O; Elnakish, MT; Hassanain, HH; Hassona, MD; Khan, M; Kulkarni, A; Kuppusamy, P; Moldovan, L; Sayyid, M | 1 |
| Chou, TF; Lee, TM; Tsai, CH | 1 |
| Chen, Y; Kiyomoto, H; Kohno, M; Mizushige, K; Ohmori, K; Sato, C; Shinomiya, K; Takeuchi, H; Yu, Y | 1 |
| Baurand, A; Bergmann, MW; Dietz, R; El Jamali, A; Freund, C; Rechner, C | 1 |
| Bezerra, DG; Mandarim-de-Lacerda, CA | 1 |
| Gu, SM; Wei, M; Wu, YH; Wu, ZG; Zhang, YY | 1 |
| Chang, NC; Chou, TF; Lee, TM; Lin, MS | 1 |
| Hamano, K; Ito, H; Kobayashi, T; Li, TS; Mikamo, A; Suzuki, R; Takahashi, M | 1 |
| Goto, Y; Kanda, M; Kinoshita, H; Miyazaki, S; Nagaya, N; Nonogi, H; Yasuda, S | 1 |
| Chang, NC; Lee, TM; Lin, MS; Tsai, CH | 1 |
| Chang, NC; Lee, TM; Lin, MS | 1 |
| Akino, M; Matsui, Y; Okamoto, H; Onozuka, H; Tsutsui, H; Xu, Z | 1 |
1 trial(s) available for pravastatin and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study.
Topics: Aged; Biomarkers; Cholesterol, LDL; Down-Regulation; Dyslipidemias; Exercise Tolerance; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Pravastatin; Prospective Studies; Quinolines; Recovery of Function; Republic of Korea; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2014 |
15 other study(ies) available for pravastatin and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Statins Reverse Postpartum Cardiovascular Dysfunction in a Rat Model of Preeclampsia.
Topics: Animals; Cardiac Output; Cardiovascular Diseases; Disease Models, Animal; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postpartum Period; Pravastatin; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Ventricular Remodeling | 2020 |
Pravastatin slows the progression of heart failure by inhibiting the c-Jun N-terminal kinase-mediated intrinsic apoptotic signaling pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cardiotonic Agents; Caspase 12; Cells, Cultured; Gene Expression; Heart Failure; Humans; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phosphorylation; Pravastatin; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2013 |
Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress.
Topics: Animals; Apoptosis; Cardiomegaly; Endoplasmic Reticulum; Fibrosis; Heart Failure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Molecular Chaperones; Myocardium; Myocytes, Cardiac; Pravastatin; Signal Transduction; Stress, Physiological; Tumor Necrosis Factor-alpha; Ventricular Pressure; Ventricular Remodeling | 2008 |
Cardiac remodeling caused by transgenic overexpression of a corn Rac gene.
Topics: Aging; Amino Acid Sequence; Analysis of Variance; Animals; Echocardiography; Genotype; Hypertrophy, Left Ventricular; Integrin alpha1; Integrin beta1; Magnetic Resonance Imaging; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Molecular Sequence Data; Mutation; Myocardium; Myosin Heavy Chains; Phenotype; Plant Proteins; Pravastatin; Promoter Regions, Genetic; rac1 GTP-Binding Protein; Superoxides; Thyroxine; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Effects of pravastatin on cardiomyocyte hypertrophy and ventricular vulnerability in normolipidemic rats after myocardial infarction.
Topics: Animals; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cell Size; Cholesterol; Endothelin-1; Heart Ventricles; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Lipids; Male; Myocardial Infarction; Myocytes, Cardiac; Pravastatin; Rats; Rats, Wistar; RNA, Messenger; Up-Regulation; Ventricular Remodeling | 2003 |
Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
Topics: Animals; Blood Glucose; Chemokine CCL2; Cholesterol; Diabetes Mellitus, Type 2; Disease Models, Animal; DNA Primers; Glucose Tolerance Test; Hydroxymethylglutaryl CoA Reductases; Immunohistochemistry; Insulin; Leptin; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pravastatin; Rats; Rats, Inbred OLETF; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1; Triglycerides; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2004 |
Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin.
Topics: Animals; Apoptosis; beta Catenin; Caspase 3; Caspases; Cell Hypoxia; Cell Line; Cytoskeletal Proteins; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Lovastatin; Male; Myocardial Infarction; Myocytes, Cardiac; Pravastatin; Rats; Rats, Wistar; Trans-Activators; Ventricular Remodeling | 2004 |
Beneficial effect of simvastatin and pravastatin treatment on adverse cardiac remodelling and glomeruli loss in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Glomerulus; Male; Myocardium; Myocytes, Cardiac; Pravastatin; Rats; Rats, Inbred SHR; Simvastatin; Triglycerides; Ventricular Remodeling | 2005 |
[Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Therapy, Combination; Fosinopril; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Pravastatin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2005 |
Additive effects of combined blockade of AT1 receptor and HMG-CoA reductase on left ventricular remodeling in infarcted rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Hemodynamics; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Imidazoles; Male; Myocardial Infarction; Pravastatin; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Tetrazoles; Ventricular Remodeling | 2006 |
Pravastatin improves remodeling and cardiac function after myocardial infarction by an antiinflammatory mechanism rather than by the induction of angiogenesis.
Topics: Angiogenesis Inducing Agents; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Bone Marrow Cells; Bone Marrow Transplantation; Cell Differentiation; Cells, Cultured; Collagen; Combined Modality Therapy; Drug Evaluation, Preclinical; Endothelium, Vascular; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Injections; Interleukin-1beta; Male; Myocardial Infarction; Neovascularization, Physiologic; Pravastatin; Random Allocation; Rats; Rats, Zucker; Single-Blind Method; Triglycerides; Ultrasonography; Vascular Endothelial Growth Factor A; Ventricular Remodeling | 2006 |
Enhanced cardiac production of matrix metalloproteinase-2 and -9 and its attenuation associated with pravastatin treatment in patients with acute myocardial infarction.
Topics: Aged; Analysis of Variance; Angina Pectoris; C-Reactive Protein; Case-Control Studies; Cholesterol; Enzyme Activation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Pravastatin; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Ventricular Dysfunction, Left; Ventricular Remodeling | 2007 |
Effects of pravastatin on ventricular remodeling by activation of myocardial KATP channels in infarcted rats: role of 70-kDa S6 kinase.
Topics: Animals; Anticholesteremic Agents; Blotting, Western; Electrophysiology; Glyburide; Heart; Immunohistochemistry; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Polymerase Chain Reaction; Potassium Channels; Pravastatin; Rats; Rats, Wistar; Ribosomal Protein S6 Kinases, 70-kDa; Ventricular Remodeling | 2007 |
Effect of pravastatin on sympathetic reinnervation in postinfarcted rats.
Topics: Animals; Blotting, Western; Cardiac Pacing, Artificial; Coronary Vessels; Disease Models, Animal; GAP-43 Protein; Glyburide; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; KATP Channels; Ligation; Male; Myocardial Infarction; Myocardium; Neurofilament Proteins; Nicorandil; Norepinephrine; Pinacidil; Polymerase Chain Reaction; Potassium Channel Blockers; Pravastatin; Rats; Rats, Wistar; RNA, Messenger; Sympathetic Nervous System; Tachycardia, Ventricular; Time Factors; Tyrosine 3-Monooxygenase; Ventricular Fibrillation; Ventricular Remodeling | 2007 |
Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice.
Topics: Angiotensin II; Animals; Blood Pressure; Cholesterol; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Failure, Diastolic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Pravastatin; rho-Associated Kinases; Ventricular Remodeling | 2008 |